Cerulean Pharma reported $-9542000 in Net Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Arrowhead Research ARWR:US $ 44.37M 107.24M
Bayer BAYN:GR € 1161M 1076M
Cerulean Pharma CERU:US $ -9.54M 3.12M
Immunogen IMGN:US $ -24.14M 13.03M
Nektar Therapeutics NKTR:US $ -145.65M 15.94M